CBGs

In this episode, we take a look at 4 Canadian cannabis stocks with potential. High Tide Cannabis (HITI.V), Heritage Cannabis Holding (CANN.C), Tetra Bio-Pharma (TBP.T) and VIVO Cannabis Inc.,…
In the times of yore before COVID-19 sent us scurrying back to our caves for self-reflection and Overlook Hotel style shenanigans, the brass here at Equity Guru sent me…
CANN focuses on extraction and the creation of derivative products for recreational and medical consumers….
Halted since July of this year, right in the midst of a six week rise, the pubco formerly known as Lifestyle Delivery Systems, now Core One Labs (COOL.C), unhalted…
Barely a few weeks after telling the Equity.Guru audience that the timeline on mushrooms would see Pure Extracts (PULL.C) focusing on its core cannabis market, evolving market dynamics and…
Yeah, I know, I know. Canadian cannabis companies are ass right now, and have been for a few years. Trust me, I’m about as out of the LP business…
Let’s take a step back. Take a breath. Maybe meditate or toss back a tequila shot. Okay, we good for a chat? It’s been a rough few years for…
Heritage is positioning itself to radically expand its sales territory….
Willow Biosciences (WLLW.T) is a Canadian biotech company based in Vancouver, BC, that is using “a proprietary yeast strain laboratory process” to produce commercial quantities of CBD and CBG”….
Sharples’ plan is to leverage Opticann’s international relationships to build “an international medical product sales footprint”….